NEWS & EVENTS
If you’re going to make Medicare coverage changes that include dropping or buying a supplemental plan — aka, Medigap — make sure you know the rules that come along with it.
Connecture’s SVP of Federal Programs Jim Yocum spoke with Money Magazine to discuss some of the potential implications from the White House’s recent efforts to curb drug costs. Connecture data was used in the analysis.
Telehealth services are becoming the “go-to” choice for many Americans, including Medicare beneficiaries. In this article, which summarizes an interview our own Jim Yocum did with Bloomberg Law, the journalist explains why CMS supports telehealth benefits as part of their Medicare strategy.
In a recent Bloomberg article, the writers show how prescription drug prices are moving up at a rate at least four times CPI inflation. Connecture data used to help construct Bloomberg’s new Drug Price Index.
A recent article from CNN highlights the obstacles many people with Type 1 diabetes face when it comes to rising drug costs (particularly insulin, in this case). Connecture’s prescription drug data was used and cited in the article.
One new idea on mitigating higher drug prices is to require the posting of costs in Rx advertising. This Kaiser Health News article provides illustrative examples of how this might look for the 10 drugs with the highest annual ad spend. Connecture data used.
Another pharmaceutical giant’s rising insulin prices, means bad news for consumers. In this article from Fortune and Kasier Health News, the journalists shed light on how lobbying impacts the prescription drug world from a cost perspective. Connecture data...
Journalist Sarah Jane Tribble wrote a fascinating piece for the Washington Post that uses Connecture drug data and spotlights the Orphan Drug Korlym. This drug has a controversial origin as “the abortion pill,” but is also used to treat Cushing’s syndrome…and its price has shot up.
Fascinating Bloomberg story that leverages Connecture’s data and highlights a Chicago-based duo that’s selling a simple Rx strategy — and companies they’ve worked with have raised prices on drugs as much as 4,116%.
Earlier this month, Connecture hosted its first-ever FMO Council Meeting in its Chicago Innovation Hub. Connecture SVP and broker expert Joe Donlan writes about that experience and his three biggest takeaways from that session.